Loading
Latest filing published 06 Jan 2026 for DiaMedica Therapeutics Inc., €24k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Charles Pauling Semba in DiaMedica Therapeutics Inc. We count 5 filings; the first trade dates from 3 January 2023 and the latest from 2 January 2026.
Every open-market trade on record is a purchase: 1 purchase worth €46k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants.
On 6 January 2026 came the latest disclosure, a share grant for €24k in DiaMedica Therapeutics Inc. The last purchase on record was published on 26 June 2023, which is 1,210 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations